Metasardinia

Scheda Evento

Congresso
THE FIL ROUGE OF ATHEROSCLEROSIS: FROM BRAIN TO HEART IMAGING
CAGLIARI,17/18 OTTOBRE 2019
c/o HOTEL REGINA MARGHERITA

Evento Accreditato ECM

Programma - Iscrizioni Chiuse

Nowadays it is widely accepted that the rupture of the atherosclerotic plaque in coronary and carotid arteries plays a fundamental role in the development of acute myocardial infarctions or cerebrovascular events.

 

Atherosclerotic disease is the underlying process of the two most important causes of death worldwide: ischemic stroke and myocardial infarction. Atherosclerosis has a high prevalence in western countries with values up to 75% of men and 62% of women aged 65 years and older. Despite advances in treatment, available routinely used screening and diagnostic methods are insufficient to identify the victims before the event occurs even if in the last years the recognition of the role of the vulnerable plaque has opened new avenues of opportunity in the field of cardiovascular medicine.

 

 In the last years, imaging techniques have explored, with a new level of detail, the atherosclerotic disease of the vessels by offering new evidences that some plaque characteristics are significantly associated to the risk of rupture and subsequent thrombosis or embolization. Moreover, the recent evidence of the anti-atherosclerotic effects determined by lipid-lowering and anti-inflammatory therapies poses a challenge for the choice of therapeutic approaches (best medical treatment – revascularization), maximized by the evidence that coronary and carotid atherosclerosis share common patterns but diverge for some important features. In this conference, we will discuss with worldwide class speakers from Europe and United States the similarities and differences between coronary and carotid artery plaque from the imaging point of view and the potential implications for systemic therapies according to the emerging evidences.

Our purpose is to present the more recent innovations in terms of early imaging of atherosclerosis and how to identify the best therapies for avoiding myocardial infarctions or cerebrovascular events.

 

 



QUOTE DI PARTECIPAZIONE